3Barath P,Fishbein MC,Cao J,et al.Detection and localization of tumor necrosisfactorin human atheroma[J].Am J Cardiol,1990,65:297.
4Musial J,PujakA,UndersA,et al.Thrombinugeneration markers and coronary heart disease risk fsctors in a Polish population sample[J].Thromb Haemost,1997,77(5):697.
5Jansen NJ,van Oevergn W,GuYJ,et al.Endotoxin release and tumor necrosis factor during cardiopulmonary bypass[J].Ann Thorac Surg,2005,67(4):744-748.
6Naik SK.Knight A.Elliott MJ.A successful modification of ultrafiltration for cardiopulmonary bypass in children.Perfusion,1991,6:41-50.
7Gu YJ.de Vries AJ,Boonstra PW,et al.Leukocyte depletion resulted in improved lung function and reduced inflammatory response after cardiac surgery[J].J Thorac Cardiovasc Surg,1996,112(2):494-500.
4[4]Jansen NJG, van Oeveren W, Gu YJ, et al.Endotoxin release and tumor necrosis factor formation during cardiopalmonary bypass. Ann Thorac Surg,1992;54:744 ~ 748
5[5]SongWan, Arnaud Marchant, Jean Marie DeSmet, et al. Human cytokine responses to cadiac transplantation and CABG.J Thorac Cardiovascelar Surgery, 1996;2:469 ~ 477
6[6]Entman ML, Smith CW. Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease.Cardiovasc Res, 1994;28:1301 ~ 1311
7[7]Song Wan, Jean Marie DeSmet, Luc Barvais, et al. Myocardium is major source of preinflammatory cytckines in pationts wndergoing cardiopalmonary bypass. J Thoracic and Cardiovascular. Surgerg, 1996;3:806 ~ 811
8[8]Jansen NTG, van Oeveren W, Broek Lvd, et al. Inhibition by dexamcthasone of the reperfution phenomina in cadiopalmonary bypass.J Cardiovasc Surg,1991; 102:515 ~ 525
9[9]Wyble CW, Desai TR. Physicologic concentrations of TNFα and IL- 1β released from reperfusion human intestine upregulates E - selection and ICAM - 1. Journal of Surgical reseach, 1996; 63:333 ~ 310
10[10]Youker K, Smith CW, Anderson DC, et al. Neutrophil adherence to isolated adult cardiac myocytes. Induction by cardiac lymph collected during ischemia and reperfusion. J Clin Invest, 1992; 89 (2): 602 ~ 609